Virginia Cancer Specialists Welcomes New Oncologist, Dr. Jelovac
Virginia Cancer Specialists Enhances Cancer Care with New Oncologist
Virginia Cancer Specialists is thrilled to announce the addition of Dr. Danijela Jelovac, a highly experienced medical oncologist specializing in breast and gynecologic cancer. This addition aims to meet the growing demand for specialized cancer care in the community. Dr. Jelovac brings significant expertise to the team, having been involved in numerous clinical trials and published extensively in renowned medical journals.
Comprehensive Cancer Care Services
The practice is committed to providing state-of-the-art integrated cancer care services, including prevention and community outreach programs. They prioritize early detection and diagnosis, leveraging cutting-edge technologies and treatment options. Their comprehensive supportive care programs help ensure that each patient receives personalized attention and care throughout their treatment journey.
Dr. Jelovac’s Background and Expertise
Dr. Danijela Jelovac earned her medical degree from the University of Belgrade before furthering her education with a fellowship at the University of Maryland. There, she specialized in the development of aromatase inhibitors and understanding mechanisms of resistance. Her extensive training continued at the prestigious Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University, where she further honed her skills in medical oncology.
Focus on Women’s Health
Since joining Johns Hopkins’ faculty in 2011, Dr. Jelovac has focused on advancing treatment options for women battling aggressive breast cancers. Her commitment to a multidisciplinary approach ensures that patients receive holistic care tailored to their unique needs.
Achievements and Community Impact
Over her career, Dr. Jelovac has not only led various clinical trials but has also taken on significant leadership roles, such as Chief of Medical Oncology at Tawam in partnership with Johns Hopkins International. Her dedication to mentoring medical oncology fellows highlights her passion for cultivating the next generation of oncologists.
Recognitions and Awards
Dr. Jelovac's contributions to the field have earned her numerous accolades, including being recognized as a Castle Connolly Top Doc in 2024. This prestigious title places her in the top 7% of practicing physicians in the U.S., reflecting her commitment to exceptional patient care and clinical excellence.
Virginia Cancer Specialists: A Leader in Cancer Care
Virginia Cancer Specialists is the largest private cancer practice in the region, known for its advanced treatment protocols and a comprehensive clinical trials program. In 2024, the practice was recognized for having the most Castle Connolly top doctors in cancer care in Virginia. Their extensive offerings include medical and radiation oncology, various surgical options, as well as support services like genetic counseling and palliative care.
Provider of Comprehensive Clinical Research
The Virginia Cancer Specialists Research Institute plays a pivotal role in advancing treatment protocols, serving as a hub for Phase I clinical trials. This commitment to pioneering research ensures that patients have access to the latest and most effective therapies available.
Patient-Centric Approach
Dr. Jelovac expressed her excitement about joining Virginia Cancer Specialists, stating that she admires the team’s dedication to patient care and innovative practices. She emphasizes the importance of multidisciplinary care, ensuring that each patient's journey is met with compassion and comprehensive support.
Contacting Dr. Jelovac
Patients interested in scheduling an appointment with Dr. Jelovac can call 571.350.8400 to visit either the Arlington or Fairfax office. This accessibility is part of Virginia Cancer Specialists’ mission to offer renowned care to the community.
Frequently Asked Questions
What is the role of Dr. Danijela Jelovac at Virginia Cancer Specialists?
Dr. Jelovac is a medical oncologist specializing in breast and gynecologic cancers, enhancing the clinical team with her expertise.
How does Virginia Cancer Specialists prioritize patient care?
The practice offers a comprehensive array of services, focusing on personalized treatment plans and supportive supportive programs for patients.
What types of cancer care services are available at Virginia Cancer Specialists?
They provide medical oncology, radiation therapy, genetic counseling, and various surgical treatments, ensuring a holistic approach to patient care.
Is there a focus on clinical research at Virginia Cancer Specialists?
Yes, the practice has a robust clinical trials program, enabling access to cutting-edge treatments and new therapies in cancer care.
How can patients get in touch with Dr. Jelovac?
Patients can call 571.350.8400 to schedule appointments with Dr. Jelovac at either the Arlington or Fairfax locations.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Discover the New Features of OKX's On-chain Earn Product
- Sri Lanka Maintains Steady Interest Rates Amid New Leadership
- Defense Metals and SRC Forge a New Era in Rare Earth Supply
- Monolith Secures New Investment to Propel Clean Energy Growth
- Cassava Sciences Faces SEC Charges; Shares Decline After News
- Uniti Group Inc. Secures New Financing for Windstream Plan
- Cordell & Cordell Welcomes Joseph P. Breda as New CEO
- Doré Copper Mining Secures $4.676 Million in New Funding
- BeiGene Updates on FDA Advisory Vote for TEVIMBRA in Cancer Care
- Lisa T. Miller Revolutionizes Healthcare Sales with New Podcast
Recent Articles
- Keith Poyser Takes Charge as EMEA Vice President at Horizon3.ai
- How Costco and Discount Tire Enhance Customer Trust and Loyalty
- Cyclic Materials Raises $53M Series B for Rare Earth Recycling
- Revolutionizing Energy Use: The Power of Efficient CPUs in AI
- ReSync Bio's Innovative Approach to Drug Discovery Automation
- Post Holdings Maintains Robust EBITDA Forecast for 2024
- Zing Health Secures $140 Million to Enhance Medicare Advantage Plans
- Burford Capital Unveils New Shares Issuance Strategy
- BNP Associates Welcomes Godspeed Capital's Strategic Investment
- Post Holdings Launches Senior Notes Offering to Raise Funds
- CytoAgents Advances Cytokine Release Syndrome Research with Grant
- Concerns Over Global Payments Growth Lead to Rating Downgrade
- Leonardo DRS Plans Q3 2024 Earnings Call and Investor Updates
- Tenaris Stock Strategy: Insights on Performance and Future
- Union Pacific Corporation to Announce Q3 2024 Earnings Soon
- Piper Sandler Boosts Confidence in argenx with Overweight Rating
- Exciting Financial Updates from GM Financial for 2024
- Amgen Inc. Secures Buy Rating with Promising Trial Outcomes
- Harley-Davidson Racing Thrives with Protolabs Manufacturing Support
- HP Inc. Enhances Collaboration Solutions with Vyopta Buyout
- Braskem and WEAV3D Achieve Recognition for Innovative Technology
- Teleflex Partners with o9 for Advanced Supply Chain Solutions
- Scholastic Elevates Jeffrey Mathews to Chief Growth Officer Role
- Galmed Pharmaceuticals Advances with Aramchol in NASH Trials
- Luxury Video Folders Transform Real Estate Presentations
- Microsoft Partners with Sublime Systems for Low-Carbon Cement
- NV5 Global's Stock Split: A Strategy for Growth and Accessibility
- United Homes Group Transitions Executive Leadership Team
- Expedia's Stock Update: Transitioning Through Challenges
- Sectigo Strengthens Global Operations with Chennai Office
- Is Bitcoin's Head and Shoulders Pattern Signaling $90,000?
- Innovative Furniture Solutions: Enhancing Community and Sustainability
- RAFTR Roofing and Westhill Join Forces for Enhanced Services
- Infrastructure Capital Advisors Boosts Dividends for Key ETFs
- Billups Expands Leadership Team for Global Growth Strategy
- Western Asset Fund Reveals Latest Financial Insights and Trends
- Heliene's Strategic $50 Million Tax Credit Deal Opens Doors
- BrandywineGLOBAL Fund Reveals Robust Financial Position
- Infusion Pump Market Growth Predictions to USD 31.41 Billion
- VALD's Growth Surge: A New Investment from FTV Capital
- Exploring the Transformative Role of AI in Healthcare Sector
- Spherix Global Insights: Transforming Financial Services for Investors
- HP Inc. Drives Innovation with Vyopta Acquisition in Collaboration
- Allvue and Octaura: A New Era in Leveraged Loan Trading
- Arq Unveils Groundbreaking Initiatives in First ESG Report
- Projected Surge in Cloud Professional Services Market to $80.08 Billion
- Energy Vault's Remarkable ESG Score Highlights Commitment to Sustainability
- Micron Technology: Analyzing AI Demand and Stock Expectations
- Revolutionizing the Game: NEWTON GOLF's Gravity Putter Launch
- Sensus Healthcare Expands Non-Invasive Cancer Treatment Access